French Regulators Shutter Facility Over GMP Issues

Drug Industry Daily
A A
France’s National Agency for Medicines and Health Products Safety has ordered French vaccine maker Theravectys to halt production at its Villejuif plant for seven months after finding numerous GMP deficiencies.

To View This Article:

Login

Subscribe To Drug Industry Daily